Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D001933:Brain Stem / Q000378:metabolism; D002531:Cerebellum / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D051379:Mice; D009021:Morphine Dependence / Q000378:metabolism*; D009270:Naloxone; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D010919:Placebos; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013239:Stereotyped Behavior / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced / Q000378:metabolism*; D013997:Time Factors; D014403:Tubocurarine / Q000494:pharmacology
D010919:Placebos; D012701:Serotonin; D009270:Naloxone; D001285:Atropine; D012110:Reserpine; D010293:Pargyline; D010830:Physostigmine; D004298:Dopamine; D014403:Tubocurarine; D009638:Norepinephrine